Our blogs

The Life Sciences industry has seen record levels of investment in recent years.
By Kelly 23 Nov, 2022
The Life Sciences industry has seen record levels of investment in recent years, largely due to the pandemic. More money means more new products, all of which require regulatory approval. The regulations themselves have had to evolve rapidly, too, creating a regulatory environment that is both thriving… and suffering from a talent shortage. Here’s how you can stay one step ahead of competitors in the race to hire top talent.
Why grassroots talent pipelines are crucial for your biomanufacturing business
By Kelly LIfe Sciences 18 Oct, 2022
​The talent landscape is pretty sparse in biomanufacturing at the moment, albeit for all the right reasons. Interest, investment and productivity are at an all-time high, which means demand has grown rapidly. This is partly down to the pandemic highlighting the importance of getting new products to market (quickly), which has led to important regulatory changes, as well as huge injections of funding. But new technologies also play a big part in this advancement.
By Kelly Life Sciences 10 Sep, 2022
​Cell Gene Therapy is the very cutting edge of medical science. The treatments are high impact - awe inspiring, even - this is what promising candidate...
Share by: